Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular function

European Journal of Heart Failure

Volumn 4, Issue 1, 2002, Pages 63-72

  Miller, Wayne L ^a   Bailey, Kent R ^a   Weston, Susan A ^a   Burnett Jr , John C ^a   Rodeheffer, Richard J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Atrial natriuretic peptide; Digitalis; Heart failure; Hemodynamics

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DESLANOSIDE; DIGITALIS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SUPINE POSITION; TREATMENT OUTCOME;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; DESLANOSIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0036157154     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00197-0     Document Type: Article

References (26)

1. The effect of digoxin on mortality and morbidity in patients with heart failure
2. Atrial natriuretic peptide elevation in congestive heart failure in the human
3. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the studies of left ventricular dysfunction (SOLVD)
4. Effects of hypercalcemia and ouabain on plasma atrial natriuretic polypeptide in anesthetized dogs
5. Hemodynamic effects of head-down tilt in normal subjects and sustained hypertensive patients
6. Atrial pressure and secretion of atrial natriuretic factor into the human central circulation
7. Studies on digitalis. IV. Observations in man of the effects of digitalis preparations on the contractility of the nonfailing heart and on vascular resistance
8. Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure
9. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure
10. Sympathoinhibitory responses to digitalis glycosides in heart failure patients
11. Sensitization of cardiac receptors (vagal offerens) by intracoronary acethyl-strophanihidin
12. Sensitization of vagal cardiopulmonary baroreflex by chronic digoxin
13. The effects of the cardiac glycosides upon the dynamics of the circulation in congestive heart failure
14. Studies on digitalis. X. Effects of ouabain on forearm resistance and venous tone in normal subjects and in patients in heart failure
15. The effect of destanoside on the duration of the phases of ventricular systole in man
16. Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man
17. Effects on maintenance digoxin therapy on systolic time intervals and serum digoxin concentrations
18. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators
19. Effects of increasing maintenance dose of digoxin on left ventricutar function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors
20. Effect of digoxin on ejection fraction in elderly patients with congestive heart failure
21. Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease
22. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic hormonal study
23. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?
24. Ouabain induces secretion of proatrial natriuretic factor by rat atrial cardiocytes
25. Ouabain. A stimulator of atrial natriuretic peptide secretion and its mechanism of action
26. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure